CAUSES OF AGING
Our science-backed products combat the 12 main causes of aging in several ways.
For us, understanding causes of aging is as important as combating its signs. While most anti-aging companies just target signs of aging, KOBHO also addresses their prevention to minimize risks.
KOBHO has selected the best and more bioavailable ingredients to tackle the 12 causes of aging. And the best doctors and the scientific studies support them.
Aging is a complex process involving loss of physiological integrity, which is associated to or responsible for age-related diseases. At the molecular level, it is characterized by the progressive accumulation of molecular damage.
Why do we age?
Recent research uncovered ten hallmarks of aging:
- Genomic Instability
- Telomere Attrition
- Epigenetic Alterations
- Disabled Macroautophagy
- Lost of Proteostasis
- Deregulated Nutrient-Sensing
- Mitochondrial Dysfunction
- Cellular Senescence
- Stem Cell Exhaustion
- Inflammaging
- Altered Intercellular Communication
- Dysbiosis
HALLMARKS OF AGING
This is an excessive damage accumulation of the genetic material being mitochondria the main target of aging-associated mutations. These damaged organelles begin to produce harmful substances that accelerate the process of premature aging and its associated diseases.
Substances that support genomic stability: magnesium.
1. Genomic Instability
As we age, the accumulated DNA damage leads to the progressive loss of telomeres - chromosomal end regions that contain your genetic material. Telomere exhaustion involves a decline of cell division capacity, and by extension, the regenerative capacity of tissues, which accelerates the development of age-related diseases.
Substances that support telomere preservation: astaxanthin and coenzyme Q10.
2. Telomere Attrition
Epigenome compounds that regulate our genes’ activity become gradually disrupted with age. It is enhanced by exposure to harmful environmental factors. Epigenetic changes affect the proper gene expression to turn genes on and off. This results in alteration of cell functions, which plays a crucial role in the development of age-related diseases.
Substances that prevent epigenetic alteration: vitamin A and C.
3. Epigenetic Alterations
Macroautophagy, also called "autophagy", is a fundamental recycling process. It involves proteostasis and other non-protein molecules. During aging it efficiency is reduced, leading to the accumulation of waste products that cause loss of cellular functionality.
Substances that contribute to the maintenance of cellular proteostasis: curcumin, resveratrol.
4. Disabled Macroautophagy
Aging and several age-related morbidities are associated with impaired protein homeostasis or proteostasis, leading to the accumulation of misfolded, oxidized, or glycated proteins that often form aggregates due to disablled macroautophagy.
Substances that contribute to the maintenance of cellular proteostasis: curcumin, resveratrol.
5. Lost of Proteostasis
When we get older, nutrient sensing pathways of cells begin to disrupt, which affects how our cells produce energy. This leads to lack of power, which compromises appropriate cell functions and accelerates aging.
Substances that support nutrient metabolism: magnesium, resveratrol.
6. Deregulated Nutrient Sensing
As we age, mitochondria, the energy powerhouse of cells, lose their functionality. Without enough energy, cells do not function properly and, consequently, drop the overall performance. Mitochondria also produces more oxidative substances which damage cells, accelerating aging.
Substances that contribute to healthy mitochondrial function: alpha-lipoic acid, astaxanthin, magnesium, and vitamin C and E
7. Mitochondrial Dysfunction
Senescent cells are former healthy cells that stopped dividing, but do not die, and secrete substances that harm healthy cells around. In the short term, cellular senescence is a protective response of the human body against damage signals. Over time, these “zombie” cells accumulate in tissues, contributing to age-related organ dysfunction, and accelerating the aging process.
Substances that help the body to eliminate senescent cells (“senolytics”): quercetin
8. Cellular Senescence
Over time, stem cells become less functional or die, as a consequence of multiple age-related genetic damage. The regenerative capacity of tissues is exhausted, since there are no new stem cells in reserve.
Substances that support stem cell maintenance: resveratrol, niacinamida, vitamins A, B6, C, and E, and zinc.
9. Stem cell exhaustion
Inflammaging is a chronic, low-grade inflammatory state that occurs silently as part of aging and may be influenced by lifestyle factors. It contributes to the development of age-related diseases such as cardiovascular disease, diabetes and neurodegenerative disorders.
Substances that reduce “inflammaging”: curcumin.
10. Inflammaging
Changes in the communication among cells at various levels are associated to “inflammaging” (age-related low-grade inflammation). Exposure to inflammatory agents prevent cells, especially those involved at the endocrine and neuronal levels from performing their functions properly.
Substances that reduce “inflammaging”: curcumin.
11. Altered Intercellular Communication
Dysbiosis is the imbalance of the gut microbiota, the microorganisms that inhabit our guts. It can contribute to the development of a variety of pathological conditions, such as obesity, type 2 diabetes, ulcerative colitis, neurological disorders, and CVDs.
Substances that maintain the gut microbiota: prebiotics, probiotics and postbiotics..
12. Disbiosis
REFERENCES
Chaudhuri, J. et al. (2018) “The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality,” Cell metabolism, 28(3), pp. 337–352. doi: 10.1016/j.cmet.2018.08.014.
van Deursen, J. M. (2014) “The role of senescent cells in ageing,” Nature, 509(7501), pp. 439–446. doi: 10.1038/nature13193.
Diggs, J. (2007) “The cross‐linkage theory of aging,” in Encyclopedia of Aging and Public Health. Boston, MA: Springer US, pp. 250–252.
Gonzalo, S. (2010) “Epigenetic alterations in aging,” Journal of applied physiology (Bethesda, Md.: 1985), 109(2), pp. 586–597. doi: 10.1152/japplphysiol.00238.2010.
Hermann, R. et al. (1996) “Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers,” European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences, 4(3), pp. 167–174. doi: 10.1016/0928-0987(95)00045-3.
Li, Z. et al. (2021) “Aging and age-related diseases: from mechanisms to therapeutic strategies,” Biogerontology, 22(2), pp. 165–187. doi: 10.1007/s10522-021-09910-5.
López-Otín, C. et al. (2013) “The hallmarks of aging,” Cell, 153(6), pp. 1194–1217. doi: 10.1016/j.cell.2013.05.039.
Roger, L., Tomas, F. and Gire, V. (2021) “Mechanisms and regulation of cellular senescence,” International journal of molecular sciences, 22(23), p. 13173. doi: 10.3390/ijms222313173.
Rossmann, M. P. et al. (2021) “Mitochondrial function in development and disease,” Disease models & mechanisms, 14(6). doi: 10.1242/dmm.048912.
Soto-Palma, C. et al. (2022) “Epigenetics, DNA damage, and aging,” The journal of clinical investigation, 132(16). doi: 10.1172/JCI158446.
Taylor, R. C. and Dillin, A. (2011) “Aging as an event of proteostasis collapse,” Cold Spring Harbor perspectives in biology, 3(5), pp. a004440–a004440. doi: 10.1101/cshperspect.a004440.
Wollin, S. D. and Jones, P. J. H. (2003) “Alpha-lipoic acid and cardiovascular disease,” The journal of nutrition, 133(11), pp. 3327–3330. doi: 10.1093/jn/133.11.3327.
von Zglinicki, T. and Martin-Ruiz, C. M. (2005) “Telomeres as biomarkers for ageing and age-related diseases,” Current molecular medicine, 5(2), pp. 197–203. doi: 10.2174/1566524053586545.